Date Filer Title Filing Type Shares Traded Price Total Held
Aug 23, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Conversion of derivative security 1,231 -- 8,585
Jan 22, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,000 $6.00 8,000
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Jun 10, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,528 -- 7,528
Aug 23, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Conversion of derivative security 5,941 -- 7,354
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 2,505 $4.59 6,891

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.